English
Segment disclosures
Company overviewGreat Elm Group, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Credit Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=geg:CreditSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1334000 | USD | 20261104 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1580000 | USD | 20261104 | Open filing evidence |
Operating Segments · Durable Medical Equipment Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 16719000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 63458000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 15634000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 46917000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 15555000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 57643000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 13117000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 42270000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 14610000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 55662000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 14131000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 41753000 | USD | 20210514 | Open filing evidence |
Operating Segments · General Corporate
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=geg:GeneralCorporateMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 203000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 876000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 230000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 645000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 243000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 579000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 162000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 298000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 91000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 159000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 114000 | USD | 20210514 | Open filing evidence |
Operating Segments · Investment Management Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1860000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 4516000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 988000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 2992000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 983000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 3210000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 728000 Restated | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 2261000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 773000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 3332000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 829000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 2585000 | USD | 20210514 | Open filing evidence |
Operating Segments · Real Estate Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 1276000 | USD | 20210514 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1276000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 3820000 | USD | 20210514 | Open filing evidence |
Administration And Service Fees · Credit Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:AdministrationAndServiceFeesMember;us-gaap:StatementBusinessSegmentsAxis=geg:CreditSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 1525000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 1261000 | USD | 20260826 | Open filing evidence |
Administration And Service Fees · Investment Management Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:AdministrationAndServiceFeesMember;us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 284000 | USD | 20221114 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 209000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 442000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 107000 | USD | 20221114 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 115000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 438000 | USD | 20220505 | Open filing evidence |
Administration Fees · Investment Management Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:AdministrationFeesMember;us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-07-01 – 2022-06-30 | 733000 | USD | 20220912 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 558000 | USD | 20220912 | Open filing evidence |
Equipment Sales · Durable Medical Equipment Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:EquipmentSalesMember;us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 9634000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 36161000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8976000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 26674000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8730000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 32293000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7309000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 23728000 | USD | 20220505 | Open filing evidence |
Property Management Fees · Investment Management Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:PropertyManagementFeesMember;us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 274000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 171000 | USD | 20220912 | Open filing evidence |
Sales And Services · Durable Medical Equipment Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=geg:SalesAndServicesMember;us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 11028000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 41720000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 10359000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 30712000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 10076000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 37460000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 8606000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 27363000 | USD | 20220505 | Open filing evidence |
Management Service Base · Credit Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceBaseMember;us-gaap:StatementBusinessSegmentsAxis=geg:CreditSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 4545000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 4993000 | USD | 20260826 | Open filing evidence |
Management Service Base · Investment Management Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceBaseMember;us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1302000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 3612000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 779000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 2550000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 876000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 2652000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 613000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 1823000 | USD | 20220505 | Open filing evidence |
Management Service Incentive · Credit Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ManagementServiceIncentiveMember;us-gaap:StatementBusinessSegmentsAxis=geg:CreditSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 0 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 4069000 | USD | 20260826 | Open filing evidence |
Service · Durable Medical Equipment Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1394000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 5559000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1383000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 4038000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1346000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 5167000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1297000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 3635000 | USD | 20220505 | Open filing evidence |
Credit Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:CreditSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 6070000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 10323000 | USD | 20260826 | Open filing evidence |
Durable Medical Equipment Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 15728000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 31283000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 15555000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 42270000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 14543000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 29153000 | USD | 20220210 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 14391000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 27622000 | USD | 20210216 | Open filing evidence |
Durable Medical Equipment Segment · Equipment Sales
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember;srt:ProductOrServiceAxis=geg:EquipmentSalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 8968000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 17698000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 8730000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 32293000 | USD | 20210921 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7309000 | USD | 20210514 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 23728000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 8411000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 16419000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 8008000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 28934000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 7549000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 21497000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 7587000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 13948000 | USD | 20210216 | Open filing evidence |
Durable Medical Equipment Segment · Sales And Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember;srt:ProductOrServiceAxis=geg:SalesAndServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 10277000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 20353000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 10076000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 37460000 | USD | 20210921 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 8606000 | USD | 20210514 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 27363000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 9544000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 18757000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 9213000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 34213000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 8933000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 25725000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 9047000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 16792000 | USD | 20210216 | Open filing evidence |
Durable Medical Equipment Segment · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:DurableMedicalEquipmentSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 1309000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 2655000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1346000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 5167000 | USD | 20210921 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 1297000 | USD | 20210514 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 3635000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 1133000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 2338000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1205000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 5279000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1384000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 4228000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1460000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 2844000 | USD | 20210216 | Open filing evidence |
General Corporate · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:GeneralCorporateMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 172000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 415000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 243000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 298000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 45000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 136000 | USD | 20220210 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 57000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 80000 | USD | 20210216 | Open filing evidence |
Investment Management And Durable Medical Equipment Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementAndDurableMedicalEquipmentSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 12888000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 46236000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 11347000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 33704000 | USD | 20220505 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 11298000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 22357000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 11059000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 40670000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9334000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 29624000 | USD | 20220505 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 10304000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 20290000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 9986000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 37545000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 9762000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 28310000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 9936000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 18548000 | USD | 20210216 | Open filing evidence |
Investment Management Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 1860000 | USD | 20221114 | Open filing evidence |
| 2021-07-01 – 2022-06-30 | 4516000 | USD | 20220912 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 988000 | USD | 20220505 | Open filing evidence |
| 2021-07-01 – 2022-03-31 | 2992000 | USD | 20220505 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 1021000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 2004000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 983000 | USD | 20221114 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 3210000 | USD | 20220912 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 728000 | USD | 20220505 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 2261000 | USD | 20220505 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 760000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 1533000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 773000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 3332000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 829000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 2585000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 889000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 1756000 | USD | 20210216 | Open filing evidence |
Investment Management Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 1021000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 2004000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 983000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 2272000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 760000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 1533000 | USD | 20220210 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 889000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 1756000 | USD | 20210216 | Open filing evidence |
Investment Management Segment · Administration Fees
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember;srt:ProductOrServiceAxis=geg:AdministrationFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 126000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 233000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 107000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 558000 | USD | 20210921 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 115000 | USD | 20210514 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 438000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 151000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 323000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 172000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 539000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 146000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 384000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 129000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 238000 | USD | 20210216 | Open filing evidence |
Investment Management Segment · Management Service Base
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:InvestmentManagementSegmentMember;srt:ProductOrServiceAxis=us-gaap:ManagementServiceBaseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 895000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-12-31 | 1771000 | USD | 20220210 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 876000 | USD | 20211112 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 2652000 | USD | 20210921 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 613000 | USD | 20210514 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 1823000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 609000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 1210000 | USD | 20220210 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 601000 | USD | 20211112 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 2793000 | USD | 20210921 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 683000 | USD | 20210514 | Open filing evidence |
| 2019-07-01 – 2020-03-31 | 2201000 | USD | 20210514 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 760000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 1518000 | USD | 20210216 | Open filing evidence |
Real Estate Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 21706000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 5993000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2004000 | USD | 20261104 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9208000 | USD | 20261104 | Open filing evidence |
| 2020-07-01 – 2021-03-31 | 3824000 | USD | 20210514 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 1276000 | USD | 20210216 | Open filing evidence |
| 2020-07-01 – 2020-12-31 | 2548000 | USD | 20210216 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1271000 | USD | 20210216 | Open filing evidence |
| 2019-07-01 – 2019-12-31 | 2544000 | USD | 20210216 | Open filing evidence |
Real Estate Segment · Administration And Service Fees
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=geg:AdministrationAndServiceFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 665000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 253000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Project Management Fees
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=geg:ProjectManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 2191000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 941000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Property Management Fees
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=geg:PropertyManagementFeesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 1318000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 1245000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Real Estate Property Sales
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=geg:RealEstatePropertySalesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 14743000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 1192000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Real Estate Rental Income
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=geg:RealEstateRentalIncomeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 181000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 317000 | USD | 20260826 | Open filing evidence |
Real Estate Segment · Management Service Base
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=geg:RealEstateSegmentMember;srt:ProductOrServiceAxis=us-gaap:ManagementServiceBaseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2026-06-30 | 2608000 | USD | 20260826 | Open filing evidence |
| 2024-07-01 – 2025-06-30 | 2045000 | USD | 20260826 | Open filing evidence |